JP2011518136A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518136A5
JP2011518136A5 JP2011504180A JP2011504180A JP2011518136A5 JP 2011518136 A5 JP2011518136 A5 JP 2011518136A5 JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011504180 A JP2011504180 A JP 2011504180A JP 2011518136 A5 JP2011518136 A5 JP 2011518136A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
hydroxyestradi
epoxy
woman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011504180A
Other languages
English (en)
Japanese (ja)
Other versions
JP5524177B2 (ja
JP2011518136A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/040102 external-priority patent/WO2009126825A1/en
Publication of JP2011518136A publication Critical patent/JP2011518136A/ja
Publication of JP2011518136A5 publication Critical patent/JP2011518136A5/ja
Application granted granted Critical
Publication of JP5524177B2 publication Critical patent/JP5524177B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011504180A 2008-04-09 2009-04-09 ほてりのためのステロイド治療 Active JP5524177B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12362208P 2008-04-09 2008-04-09
US61/123,622 2008-04-09
PCT/US2009/040102 WO2009126825A1 (en) 2008-04-09 2009-04-09 Steroid treatment for hot flashes

Publications (3)

Publication Number Publication Date
JP2011518136A JP2011518136A (ja) 2011-06-23
JP2011518136A5 true JP2011518136A5 (cg-RX-API-DMAC7.html) 2012-05-31
JP5524177B2 JP5524177B2 (ja) 2014-06-18

Family

ID=41162250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011504180A Active JP5524177B2 (ja) 2008-04-09 2009-04-09 ほてりのためのステロイド治療

Country Status (10)

Country Link
US (2) US20090258040A1 (cg-RX-API-DMAC7.html)
EP (1) EP2278880B1 (cg-RX-API-DMAC7.html)
JP (1) JP5524177B2 (cg-RX-API-DMAC7.html)
KR (1) KR101602802B1 (cg-RX-API-DMAC7.html)
CN (1) CN102056484B (cg-RX-API-DMAC7.html)
AU (1) AU2009234159B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910637A2 (cg-RX-API-DMAC7.html)
DK (1) DK2278880T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010011063A (cg-RX-API-DMAC7.html)
WO (1) WO2009126825A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3068590A1 (en) 2017-07-06 2019-01-10 Dignity Health Novel treatment for hot flushes
KR20210151836A (ko) 2019-04-15 2021-12-14 페린 파마슈티칼즈, 인코포레이티드 편두통의 치료
WO2024254005A1 (en) * 2023-06-04 2024-12-12 Vistagen Therapeutics, Inc. 1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance
US20250312356A1 (en) * 2024-04-08 2025-10-09 Vistagen Therapeutics, Inc. Treatment of dysmenorrhea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern
US6140316A (en) * 1991-01-07 2000-10-31 Pherin Corporation Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) * 1991-10-03 1994-04-19 Pherin Corporation Combined neuroepithelial sample delivery electrode device and methods of using same
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6057439A (en) 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
DE69736833T2 (de) * 1996-07-23 2007-05-24 Pherin Pharmaceuticals, Inc., Menlo Park Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
RS20080200A (sr) * 2005-11-14 2009-07-15 Rinat Neuroscience Corp., Antagonistička antitela usmerena protiv kalcitonina, peptida povezanog sa genom, i postupak njihovog korišćenja
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Similar Documents

Publication Publication Date Title
Burkman et al. The evolution of combined oral contraception: improving the risk-to-benefit ratio
JP2012524112A5 (cg-RX-API-DMAC7.html)
JP2011225596A5 (cg-RX-API-DMAC7.html)
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
JP2011513437A5 (cg-RX-API-DMAC7.html)
JP2011518136A5 (cg-RX-API-DMAC7.html)
KR20120085353A (ko) 가금류, 가축의 조류독감 및 호흡기 질환 치료제 및 예방제
MX2013003523A (es) Composicion farmaceutica de dosis baja.
JP2016504361A5 (cg-RX-API-DMAC7.html)
Santini Human respiratory syncytial virus and Th1 chemokines
MY172530A (en) Method for treating gynecological diseases
JP2019535830A5 (cg-RX-API-DMAC7.html)
CL2015003014A1 (es) Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas.
JP2015524460A5 (cg-RX-API-DMAC7.html)
CN104666531A (zh) 一种小儿退热贴及其制备方法
Bhadra et al. Role of oral misoprostol for treatment of incomplete abortion
CN102485242B (zh) 一种疏风清热解毒利咽的中药组合物及制备方法
CN102068676A (zh) 一种治疗冻疮的药物
CN104224808A (zh) 米诺环素用于妊娠期间应激所致的后代神经精神损伤的保护作用
CN103566462A (zh) 一种复合阴道给药装置、其制备方法和应用
CN106176967B (zh) 一种舒张气管平滑肌的药物组合物
CN101579389A (zh) 一种治疗骨质疏松症的药物组合物
CN215084107U (zh) 药物给药器
JP2015520763A5 (cg-RX-API-DMAC7.html)
CN103893413A (zh) 一种用于治疗湿疹或皮肤瘙痒的药物组合物及制备方法